Switch to:
GuruFocus has detected 1 Warning Sign with Cascadian Therapeutics Inc \$CASC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Change In Receivables
\$0.00 Mil (As of Dec. 2016)

Cascadian Therapeutics Inc's change in receivables for the quarter that ended in Dec. 2016 was \$0.00 Mil. It means Cascadian Therapeutics Inc's accounts receivables increased by \$0.00 Mil from Sep. 2016 to Dec. 2016 .

Cascadian Therapeutics Inc's change in receivables for the fiscal year that ended in Dec. 2016 was \$-0.04 Mil. It means Cascadian Therapeutics Inc's accounts receivables declined by \$0.04 Mil from Dec. 2015 to Dec. 2016 .

Cascadian Therapeutics Inc's accounts receivables for the quarter that ended in Dec. 2016 was \$0.24 Mil.

Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

In Ben Grahams calculation of liquidation value, Apple Inc's accounts receivables are only considered to be worth 75% of book value. Cascadian Therapeutics Inc's liquidation value for the three months ended in Dec. 2016 was \$54.08 Mil.

Definition

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Cascadian Therapeutics Inc's Days Sales Outstanding for the quarter that ended in Dec. 2016 is calculated as:

 Days Sales Outstanding = Account Receivable / Revenue * Days in Period = 0.238 / 0 * 91 =

2. In Ben Grahams calculation of liquidation value, Cascadian Therapeutics Inc's accounts receivable are only considered to be worth 75% of book value:

Cascadian Therapeutics Inc's liquidation value for the quarter that ended in Dec. 2016 is calculated as:

 Liquidation Value = Cash and Cash Equivalents - Total Liabilities + (0.75 * Account Receivable) + (0.5 * Inventory) = 62.805 - 8.908 + 0.75 * 0.238 + 0.5 * 0 = 54.08

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Related Terms

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.